Titan Pharmaceuticals, Inc.: capex
| Value | {"amount": 44000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2019-01-01 – 2019-03-31 |
| Status | current |
| Entity | Titan Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:08:36.321546+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/0a01a0bb-2155-453f-a207-ba466ffd3d32
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001144204-19-026546 · Open the official SEC filing →Retrieved: 2026-08-19T09:08:36.321546+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000910267/capex/2019-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/0a01a0bb-2155-453f-a207-ba466ffd3d32
History
- no predecessors — first report